Arrhythmia

According to Dr. Rath’s Cellular Medicine, irregular heartbeat (arrhythmia) most often develops as a result of a chronic deficiency of specific micronutrients in the heart muscle cells causing insufficient bio-energy production in so called “electrical heart cells” responsible for the generation and timely delivery of electrical stimuli to the heart muscle.  Dysfunction of these cells can result in irregular heartbeat. Therefore the primary approach to normalizing heartbeat should include a supply of specific micronutrients critical in biological energy production in the cells, such as vitamin C, B vitamins, Coenzyme Q10, lysine, magnesium, calcium and potassium among others.

Regulation of heartbeatRegulation of heartbeat

The human heart at rest beats approximately 60-80 times a minute (86,400 times daily) and contracts approximately 100,000 times daily pumping about 10,000 liters (2,642 gallons) of blood through the cardiovascular system. The electrical impulse that makes the cardiac muscle beat originates in the specialized cells located in the sinus node. These specialized cells form of a type of living pacemaker which spontaneously generates a rhythm of the heart’s regular contractions and transfers the tempo to the rest of the heart muscle.

Arrhythmia, manifested by irregular heart contractions is a disorder that often develops independently and can occur at any age. It often appears after a heart attack or in patients suffering from heart failure. Worldwide more than 100 million people suffer from this problem, which can vary in its severity ...hide content

How to recognize arrhythmiaHow to recognize arrhythmia

Arrhythmia  is caused by disturbances in the creation or conduction of the electrical impulse that is responsible for a regular heartbeat. There are many types of arrhythmias and some of them are harmless, while others carry a risk of a sudden death.

Arrhythmia can develop as a consequence of coronary heart disease, a heart attack, excessive use of alcohol, smoking, viral infection, or thyroid disease.  Arrhythmia can be triggered by certain pharmaceutical drugs, by a mineral imbalance and excessive physical strain. In many cases the underlying cause of arrhythmia is unknown and is medically defined as “paroxysmal arrhythmia.”

Episodes of heart palpitations, or racing or irregular heartbeats, can be accompanied by drowsiness, dizziness, confusion and speech disorders. Serious symptoms can worsen existing diseases (i.e., angina pectoris and heart failure). In extreme cases arrhythmia can result in sudden fatal cardiac arrest. ...hide content

Conventional approachesConventional approaches

Unfortunately conventional medicine does not look into micronutrient deficiencies as the underlying cause of impaired function of the heart’s electrical cells. Its therapeutic options are confined to treating the symptoms of disease. Beta-blockers and other drugs are used to normalize heartbeat, however their most frequent side effect is … arrhythmia. Slow form of arrhythmia with long pauses between heartbeats is treated by implanting a pacemaker. In more severe cases part of a cardiac muscle is burned (cauterization) in order to block disruptive electrical impulses. ...hide content

The Cellular medicine approach in arrhythmia involves biological synergyThe Cellular medicine approach in arrhythmia involves biological synergy

Cellular Medicine focuses on the causes, prevention and natural correction of many health problems at the level of billions of cells building our bodies.  All cells require sufficient amounts of vitamins, minerals, amino acids and other nutrients to function optimally. Most of these nutrients are biocatalysts of thousands of enzymatic reactions taking place in every cell and, if they are not provided in optimum amounts, the cells and consequently the organs start to malfunction, leading to diseases.

According to Cellular Medicine, in most cases irregular heart rhythm can develop as a result of a long-term deficiency of micronutrients that are needed to generate optimum quantities of biological energy required by the “electrical” heart cells. Therefore, the most effective approach to maintaining healthy heart rhythm is by assuring that these micronutrients are provided regularly and in optimal amounts.

Cellular Medicine has introduced the synergy-based approach as the most effective way of correcting micronutrient deficiencies while assuring metabolic balance in our body’s cells.   The use of a single nutrient can lead to either unmasking an underlying deficiency of other micronutrients or causes shift in metabolic balance towards an undesired level. The synergy approach is established on the fact that all cellular functions in the body are based on synergy and the cooperation between nutrients is the basis of metabolism. Therefore in our research we focus on defining and testing synergistically acting essential nutrient teams as the most effective way to assure balanced cellular metabolism. ...hide content

Key components of nutrient synergy for maintaining optimum heart healthKey components of nutrient synergy for maintaining optimum heart health

Vitamin B1, B2, B3, B5, B6, B12 and biotin are important energy carriers in cellular metabolism.  Vitamin B1 is critical for the optimum function of the cardiac muscle cells. People who are taking diuretics are particularly affected by a shortage of B vitamins and other water-soluble micronutrients.

Coenzyme Q10 (CoQ10) is the key component in the energy formation cycle in the mitochondria, the biological power source of the cells.  An optimum supply of CoQ10 is especially important for the cardiac muscle cells because of their high demands for bioenergy. Muscle tissues are the richest source of this nutrient, therefore vegetarians are at risk of  CoQ10 deficiency. CoQ10 also has antioxidant properties.

Carnitine can be produced in our body cells from the amino acids lysine and methionine. Lysine is not manufactured in our body and since it comes only from diet, its deficiency is likely. In addition, carnitine production requires vitamin C, iron, vitamin B6 and niacin. Carnitine is essential for transporting fatty acids into the mitochondria where they are burned for energy. Its role is very important because fatty acids are the primary energy source for the heart muscle.

Vitamin C is needed for carnitine production and is an important mediator of energy production in the cells. Vitamin C is the universal antioxidant in the body protecting cells and all metabolic components against damage from oxidation.

Vitamin E protects cell membranes and fatty components against damage from free radicals. Excessive free radical production has been associated with aging, tissue damage and various diseases.

Taurine is an amino acid produced from cysteine and vitamin B6. Especially low taurine levels have been detected in people after suffering a heart attack. Taurine is highly utilized by the heart and helps to stabilize cell membranes.  It is also very important for optimum heart function and maintaining regular heartbeat. ...hide content

Clinical confirmation of the benefits of nutrient synergy in arrhythmiaClinical confirmation of the benefits of nutrient synergy in arrhythmia

The health benefits of the micronutrient synergy approach in patients suffering from arrhythmia were confirmed in a double-blind, placebo-controlled randomized clinical trial in 131 patients.  In this study the patients took the specific micronutrient composition in addition to their standard medication for a period of six months. The results achieved were statistically significant, which means that they were not due to chance.

The results of the clinical study showed that the synergistic action of specific cellular nutrients, especially vitamin C, CoQ10, the B-complex group, the amino acids lysine and carnitine, as well as calcium, magnesium, and other properly balanced nutrients, decreased arrhythmic episodes after six months of their use. About half of the patients (48% of study participants) were free of arrhythmic episodes, and approximately 70% of the participants experienced an improvement in their health condition. Even patients with more advanced stages of the disease showed improvements in this heart condition with longer use of the cellular nutrients.

The synergistic action of cellular nutrients also showed a significant effect in improving the general well-being of the patients, their vitality, and mental health status. (Total score: 90 in the vitamin group versus 47 in the placebo group.) ...hide content

 

Women Cancers

Breast cancer

Breast cancer is the most common cancer diagnosed in women, and is the third most common cancer worldwide. Breast cancer is second only to lung cancer as a cause of death in women. Incidences of and death from breast cancer are generally increasing throughout the world, primarily in the industrialized countries. The incidence of breast cancer increases with age, but the rate of this increase diminishes with menopause. There is no complete cure for cancer, and the five-year survival rate of patients with breast cancer stays at about 88%. read more...

Wide promotion and use of estrogen-based therapies have been implicated in an increased risk of breast cancer as well as ovarian and uterine cancer and other health problems. This was confirmed in the largest clinical study to date conducted in more than 16,000 women taking Hormone Replacement Therapy. This study was discontinued because of increased risk of developing breast cancer, heart disease and other problems.

Conventional medicine treats breast cancer with surgery, radiation, chemotherapy or hormonal therapy. These treatments are associated with numerous and often serious side effects and the recurrence of cancer, especially when cancer is diagnosed at later stages.

We have studied the effects of micronutrients on prevention, development and progression of breast cancer using different approaches.

In vitro studies have shown that a synergy of micronutrients has anti-tumor potential by inhibiting cell growth, MMP secretion and cancer cell invasion through Matrigel of both estrogen- positive (ER+) and estrogen-negative (ER-) cancer cell lines, MCF-7 and MDA-MB-231, respectively. The effectiveness of a combination of these nutrients in inhibiting the growth of MDA-MB-231 xenografted tumors in nude mice have been documented in vivo.

Micronutrients incorporated in the diet were also effective in preventing the development of chemically-induced breast cancer. We have observed that even  when these micronutrients were administered at the later stages of tumor growth (tumors were already established)  there was a dramatic decrease in tumor growth rate. Interestingly, the majority of tumors that developed under micronutrient supplementation were benign. ...read less

Cervical Cancer

Cervical cancer is the second most common cancer of the female reproductive tract. It is currently the third leading cause of cancer death in women. With the introduction of Papanicolaous test screening for cervical cancer its rates has been declining in the the developed world. The incidence of cervical cancer is higher among women with a history of sexually transmitted diseases. read more...

Our in vitro studies have shown a great anti-cancer potential of the specific combination of micronutrients in cervical cancer. These nutrients were effective in inhibiting critical mechanisms involved in cancer development and spread, such as cell growth, MMP expression and invasion through extracellular matrix. ...read less

Ovarian cancer

Ovarian cancer, the deadliest of the gynecologic cancers, is the fifth leading cause of cancer death among U.S. women, due to metastasis. Currently, 50% of the women diagnosed with ovarian cancer die from it within five years. read more...

Our study results indicate that a synergistically acting micronutrient mixture is effective in inhibition of ovarian cancer cells growth and their invasion through connective tissue and it can completely curtail the secretion of MMPs by these cells. ...read less

Why are cancers of reproductive organs so frequent?

Estrogen plays an important role in tissue remodeling, such as the one occurring monthly during ovulation, as well as those associated with pregnancy or breastfeeding. The restructuring of connective tissue occurring in the breast, ovaries and uterus require secretion of collagen digesting enzymes, such as MMPs, plasmin and others. read more...These enzymes are needed for temporary dissolving of connective tissue (ie, releasing an egg from the ovary wall or formation of milk ducts in the breast). However, the activity of these enzymes remains under tight biological control so the destruction of the tissue does not continue.

Dr. Rath suggested that these body organs in which physiological functions involve enzymatic restructuring such as reproductive organs, are prone to developing aggressive cancers. In these organs, enzymatic activity can spin out of control facilitating the spread and invasion of abnormal cells in the body (For more information, please click here). ...read less

Relevant publications

Breast Cancer

See publication list

Cervical Cancer

See publication list

Ovarian Cancer

See publication list

Skin Cancer and Melanoma

Skin cancers can arise from various skin layers and cell types. The exposure of the skin to the environment has a special relevance because of a wide variety of carcinogens that can interact directly with the genetic material of the skin cells and increase the risk for skin cancer. Skin cancer can be divided into melanoma and non-melanoma types.

Melanoma is a skin tumor that originates from the melanocytes and ranks as the seventh leading type of cancer in the U.S. The incidence of melanoma is ten times more in Caucasians compared to African Americans. In women the incidence of melanoma is increasing faster than any other cancer, except lung cancer. Excessive sun exposure is considered the principle cause of melanoma. Individuals with fair skin, blue eyes, blonde or red hair are at higher risk for melanoma.

There are two types of non-melanoma skin cancers: basal cell carcinoma and squamous cell carcinoma.

Basal cell carcinoma, the most common cancer in the U.S. among Caucasians, accounts for 77% of all skin cancers and has the following characteristics: shiny skin, pink color, nodular variant, pigmented basal cell carcinoma, sclerosing. read more...

Squamous cell carcinomas, which are predominantly found in elderly Caucasians, appear on the back of the hand, forearm, and neck; the nodule may be ulcerated and enlarged.

We investigated the effects of a specific micronutrient combination on human melanoma and murine melanoma cell lines using in vitro and in vivo approaches. Our in vitro studies indicate that these micronutrients are effective in inhibiting cancer cells proliferation responsible for tumor growth as well as, their invasion through Matrigel and MMP secretion, which are essential mechanisms of metastasis . In addition, we observed that dietary supplementation with these micronutrients suppressed growth of the xenografted melanoma cells and murine melanoma tumors in nude mice. ...read less

Relevant Publications

Skin Cancer

See publication list

Men Cancers

Prostate cancer

Prostate cancer, the number one incidence of cancer in men and second most deadly cancer in the U.S., primarily affects males 55 and older, and is more common in African American males than Caucasian males. Prostate cancer occurs more frequently in the industrialized countries, which account for about 75% of cases; and the highest rates are found in Europe, North America and Australia. Prostate cancers have been identified as hormone dependent (androgen-sensitive) and independent (androgen-insensitive).

Current diagnostic methods, such as PSA tests and digital rectal exams, have helped with early detection of prostate cancer. Standard treatment of prostate cancer consists of surgery (prostatectomy), hormonal therapy and radiotherapy. read more...

We investigated the effect of selected micronutrients working in synergy using both in vitro and in vivo approaches. These micronutrients included vitamin C, lysine, proline, N-acetylcysteine, arginine, green tea extract and other micronutrients.

Our in vitro studies were conducted using androgen insensitive human prostate cancer cell lines (PC-3 and DU-145) and androgen sensitive cell line (LNCaP). The results demonstrated that this synergy of micronutrients is effective in the suppression of prostate cancer cell growth, inhibition of MMP secretion, and other aspects. The invasion of both androgen sensitive and androgen insensitive prostate cancer cells through Matrigel was completely inhibited by this nutrient mixture, which implies its effectiveness in curbing prostate cancer cells invasion in the tissue, and the potential to control metastasis.

We also investigated the effect of micronutrient synergy on the growth of tumors induced by implanting PC-3 cells in athymic nude mice. In vivo data showed that the micronutrient mixture strongly suppressed the growth of tumors which was accompanied by the inhibition of Ki 67 index (indicator of cells division rate) and expression of MMPs (indicator of metastasis and tumor growth), VEGF (Vascular Endotherial Growth Factor – involved in angiogenesis and tumor growth), and fibronectin ( involved in metastasis and other cancer effects).

The administration of the micronutrient mixture in the diet did not cause any adverse effects.

These data suggest a strong potential of this nutrient mixture as a safe and effective approach in prostate cancer. ...read less

Testicular Cancer

Testicular cancer is rare but still represents one of the most frequently occurring cancers in young men. Caucasian men contract testicular cancer more often than African American men. Its peak frequency is observed in early adulthood, between the ages of 20-35, and testicular cancer is rather uncommon after the age of 40.

Risk factors include undescended testes, Klinefelter syndrome and being HIV positive. While chemotherapy has been shown to work in testicular cancer in a number of cases, it is associated with severe side effects and a risk of various diseases. There is a need to develop safe and effective approaches in this type of cancer. read more...

We investigated the effects of micronutrient synergy on human testicular cancer cells. In particular we tested whether this nutrient mixture can affect cancer cell proliferation, expression of connective tissue digesting enzymes (MMPs) and cancer cell invasive potential. Our results suggested that these selected micronutrients working in synergy have anti-cancer potential in testicular cancer by inhibiting critical steps in cancer development such as MMP expression and cancer cells invasion. ...read less

Relevant Publications

Prostate Cancer

See publication list

Testicular Cancer

See publication list

Sarcomas and Malignancies of the Bone

Malignancies of the soft tissues (6%) and bone (5%) account for more than 10% of cancers diagnosed in children, adolescents, and young adults. Benign musculoskeletal neoplasms are one hundred times more common than malignant soft tissue tumors.

  • Fibrosarcoma, an aggressive and highly metastatic cancer of the connective tissue, primarily develops in the metaphyses of long tubular bones, and affects both children and adults. The poor prognosis associated with fibrosarcoma can be attributed to both the aggressive metastatic spread characteristic of this cancer and lack of efficacy in current treatment.
  • Liposarcoma, a malignancy of fat cells, is the most common soft tissue sarcoma with an annual incidence of 2.5% cases per million.
  • Osteosarcoma accounts for about 60% of malignant bone tumors between the ages of 10 to 20. The remaining bone malignancies in children and adolescents are Ewing sarcomas. Ewing sarcomas are histologically similar and identical to peripheral primitive neuroectodermal tumors.
  • Chondrosarcomas most often affect older adults.
  • Rhabdosarcoma, the most common soft tissue sarcoma is mesenchymal in origin, and affects infants and children up to five years (mostly males).
  • Synovial sarcoma, a soft tissue cancer that most often occurs around leg or arm joints, has a 50% rate of metastasis.

read more...We investigated the effect of micronutrient synergy in vitro on human rhabdosarcoma, liposarcoma and chondrosarcoma cell lines and, in vitro and in vivo on human osteosarcoma, synovial sarcoma and fibrosarcoma cell lines. Click below for scientific publications on these topics.

Our results suggest that a micronutrient mixture containing vitamin C, EGCG, Lysine, Proline and other natural components is effective in inhibiting cancer cells proliferation, secretion of MMPs and cancer invasion through Matrigel in vitro and in inhibiting the tumor growth of grafted saracoma cell lines in nude mice. ...read less

Relevant Publications

Fibrosarcoma

See publication list

Subcategories

Page 3 of 6